Vancouver's Absci Lab, a pioneer in synthetic biology, has secured a massive $125 million investment from new investors. This funding will fuel the company's innovative research and development, pushing the boundaries of life science innovation beyond the Puget Sound region. Absci Lab's groundbreaking work promises to revolutionize the industry, and this latest investment is a testament to its potential.